Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02594826 · ClinicalTrials.gov registry record · NA
Cervical Cancer Screening Intervention Among Korean American Women
A NA study of Cervical Carcinoma, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 744
- Enrollment target
- 1
- Study location
NCT02594826: Completed NA study of Cervical Carcinoma, sponsored by Fox Chase Cancer Center.
NCT02594826 is a NA study of Cervical Carcinoma that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 744 participants, above the 506-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02594826, a NA study of Cervical Carcinoma, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 744 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Korean American women. Due to the multiple factors that contribute to screening uptake, an educational program customized to Korean culture combined with navigation assistance may be effective in increasing the number of Korean American women who can access cervical cancer screening.
Primary Outcome
Number of women who receive a Pap smear test in each group
Conditions Studied
Interventions
- BEHAVIORAL Culturally appropriate intervention
- BEHAVIORAL General health education control
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 744 participants |
| Start Date | 2009-02 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT02594826 record still lists
NCT02594826 is an interventional study that assigns participants to a tested intervention. The registered 744 participants enrollment target is mid-sized for trials with a published cap, above the 506-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (47% higher).
The record links to 1 condition, with Cervical Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Culturally appropriate intervention is the first listed.
NCT02594826 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02594826 about?
NCT02594826 is a clinical study titled "Cervical Cancer Screening Intervention Among Korean American Women". This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Korean American women. Due to the multiple factors that contribute to screening uptake, an educational program customized to Korean culture combined with ...
What is the current status of trial NCT02594826?
This trial is currently completed. It is a NA study. The enrollment target is 744 participants. The study started on 2009-02. Estimated completion is 2014-12.
What conditions does trial NCT02594826 study?
This clinical trial studies the following conditions: Cervical Carcinoma.
What interventions are being tested in trial NCT02594826?
The interventions under investigation include: Culturally appropriate intervention (BEHAVIORAL), General health education control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02594826?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02594826 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02594826's enrollment target sits among peer trials
744 4th of 25 higher than 22 of 25 other Cervical Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
The Ohio State University (OSU) SCREEN Community Program
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
ACTIVE NOT RECRUITING · NA
-
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia